StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

Research analysts at StockNews.com began coverage on shares of ObsEva (NASDAQ:OBSV) in a report released on Tuesday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

ObsEva has a 1 year low of $0.08 and a 1 year high of $2.14. The company has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.